Mar 16, 2022 / 12:45PM GMT
Ami Fadia - Needham & Company, LLC, Research Division - Research Analyst
Good morning, everyone, again. Welcome to the second session with Harmony Bioscience. It's my pleasure to have Jeff Dayno, who's the Chief Medical Officer of Harmony. He has significant experience in leadership roles in multiple companies as well as clinical and academic medicine as a principal investigator. We are lucky to have him today in the session. Jeff, thank you so much.
Perhaps if we could maybe just kick off with some questions, if that's okay with you.
Jeffrey M. Dayno - Harmony Biosciences Holdings, Inc. - Chief Medical Officer
Yes, that sounds great, Ami. So Good morning. It's a pleasure to be here with you this morning. And on behalf of the whole team at Harmony, thank you very much for the invitation and opportunity to participate in Needham's first annual Neuroscience forum. It's great to be here.
Questions and Answers:
Ami Fadia - Needham & Company, LLC, Research Division - Research AnalystOkay. Great.
Trustpilot
